URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Charles Heckler

Concepts (131)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
5
2009
155
0.850
Why?
Breast Neoplasms
8
2009
666
0.690
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2009
436
0.590
Why?
Antineoplastic Agents
6
2009
628
0.570
Why?
Antiemetics
2
2011
55
0.410
Why?
Fatigue
3
2009
124
0.390
Why?
Acupressure
2
2009
15
0.360
Why?
Exercise
2
2009
181
0.340
Why?
Vomiting
4
2009
116
0.320
Why?
Hospital Information Systems
1
1996
8
0.290
Why?
Abstracting and Indexing as Topic
1
1996
10
0.290
Why?
Insurance, Health, Reimbursement
1
1996
35
0.290
Why?
Medical Records Systems, Computerized
1
1996
35
0.280
Why?
Neoplasms
4
2009
743
0.280
Why?
Middle Aged
15
1980
10013
0.260
Why?
Quality of Life
4
2009
528
0.250
Why?
Tai Ji
2
2011
22
0.250
Why?
Prostatic Neoplasms
2
2009
540
0.240
Why?
Survivors
2
2011
118
0.230
Why?
Doxorubicin
2
2009
105
0.220
Why?
Boronic Acids
1
2012
30
0.210
Why?
Pyrazines
1
2012
34
0.210
Why?
Antibodies, Monoclonal, Humanized
1
2012
94
0.210
Why?
Ginger
1
2011
5
0.210
Why?
Multiple Myeloma
1
2012
75
0.200
Why?
Phytotherapy
1
2011
18
0.200
Why?
Sleep
1
2011
58
0.200
Why?
Benzhydryl Compounds
1
2010
13
0.190
Why?
Complementary Therapies
1
2011
39
0.190
Why?
Sleep Disorders
1
2011
70
0.190
Why?
Female
15
1980
20222
0.190
Why?
Dentate Gyrus
1
2010
26
0.190
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Aged
10
1980
7392
0.180
Why?
Exercise Tolerance
1
2009
12
0.180
Why?
Carboplatin
1
2009
29
0.180
Why?
Health Status Disparities
1
2010
47
0.180
Why?
Tumor Markers, Biological
1
2011
240
0.170
Why?
Insulin-Like Growth Factor I
1
2010
106
0.170
Why?
Stress Disorders, Post-Traumatic
1
2010
72
0.170
Why?
Blood-Brain Barrier
1
2010
110
0.170
Why?
Cerebral Cortex
1
2011
257
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.170
Why?
Cisplatin
1
2009
93
0.170
Why?
Gene Expression Regulation, Neoplastic
1
2011
266
0.170
Why?
Double-Blind Method
4
2010
996
0.160
Why?
European Continental Ancestry Group
1
2010
238
0.160
Why?
Adult
10
1980
11572
0.160
Why?
Insulin
1
2011
670
0.150
Why?
African Americans
1
2010
230
0.150
Why?
Humans
17
1980
37165
0.150
Why?
Cognition Disorders
1
2011
291
0.150
Why?
Radiotherapy
1
2009
198
0.150
Why?
Cytokines
1
2011
575
0.150
Why?
Stress, Psychological
1
2010
290
0.140
Why?
Aged, 80 and over
5
2009
2588
0.130
Why?
Pilot Projects
3
2009
446
0.130
Why?
Male
10
1980
20139
0.120
Why?
Prochlorperazine
2
2009
11
0.100
Why?
Serotonin Antagonists
2
2009
21
0.100
Why?
Hematology
1
1980
13
0.090
Why?
Neoplasm Staging
2
2009
354
0.090
Why?
Prognosis
2
2009
1078
0.080
Why?
Hospital Bed Capacity, under 100
1
1996
1
0.070
Why?
Insurance Claim Reporting
1
1996
7
0.070
Why?
Pennsylvania
1
1996
31
0.070
Why?
Hospitals, Community
1
1996
72
0.070
Why?
Diagnosis-Related Groups
1
1996
45
0.070
Why?
Age Factors
2
2009
1152
0.070
Why?
Medicaid
1
1996
100
0.070
Why?
United States
2
1996
2847
0.060
Why?
Medicare
1
1996
147
0.060
Why?
Receptors, Neurokinin-1
1
2012
7
0.060
Why?
Quinuclidines
1
2012
6
0.060
Why?
Granisetron
1
2012
7
0.060
Why?
Intention to Treat Analysis
1
2012
10
0.060
Why?
Morpholines
1
2012
43
0.050
Why?
Isoquinolines
1
2012
63
0.050
Why?
Treatment Outcome
2
2009
2671
0.050
Why?
Polysomnography
1
2011
25
0.050
Why?
Serotonin 5-HT3 Receptor Antagonists
1
2011
7
0.050
Why?
Vomiting, Anticipatory
1
2011
21
0.050
Why?
Massage
1
2011
9
0.050
Why?
Drug Administration Schedule
1
2012
374
0.050
Why?
Dexamethasone
1
2012
188
0.050
Why?
Drug Therapy, Combination
1
2012
397
0.050
Why?
Suggestion
1
2010
6
0.050
Why?
Relaxation Therapy
1
2010
15
0.050
Why?
Interleukin-8
1
2011
111
0.050
Why?
Bromodeoxyuridine
1
2010
68
0.050
Why?
Energy Metabolism
1
2011
137
0.050
Why?
Neurogenesis
1
2010
30
0.050
Why?
Chemokine CCL2
1
2011
128
0.050
Why?
Fluorouracil
1
2010
78
0.050
Why?
Placebos
1
2010
185
0.050
Why?
Paclitaxel
1
2010
59
0.050
Why?
Cyclophosphamide
1
2010
177
0.050
Why?
Weight Loss
1
2010
79
0.040
Why?
Intervention Studies
1
2009
35
0.040
Why?
Muscle Strength
1
2009
25
0.040
Why?
Health Status Indicators
1
2010
112
0.040
Why?
Home Care Services
1
2009
48
0.040
Why?
Time Factors
2
1980
3234
0.040
Why?
Psychometrics
1
2010
232
0.040
Why?
Health Status
1
2011
306
0.040
Why?
Continental Population Groups
1
2009
125
0.040
Why?
Analysis of Variance
1
2011
749
0.040
Why?
Patient Education as Topic
1
2010
227
0.040
Why?
Interleukin-6
1
2011
339
0.040
Why?
Adaptation, Psychological
1
2010
212
0.040
Why?
Patient Compliance
1
2009
177
0.040
Why?
Dose-Response Relationship, Drug
1
2011
1142
0.040
Why?
Survival Rate
1
2009
619
0.040
Why?
Sex Factors
1
2009
613
0.040
Why?
Prevalence
1
2009
582
0.040
Why?
Severity of Illness Index
1
2011
943
0.040
Why?
Incidence
1
2009
682
0.040
Why?
Cell Proliferation
1
2010
520
0.030
Why?
Adolescent
2
1980
5044
0.030
Why?
Mice, Inbred C57BL
1
2010
1700
0.030
Why?
Young Adult
1
2009
1084
0.030
Why?
Risk Factors
1
2009
2331
0.030
Why?
Neurons
1
2010
1105
0.030
Why?
Computers
1
1980
83
0.020
Why?
False Positive Reactions
1
1980
88
0.020
Why?
Reference Values
1
1980
453
0.020
Why?
Erythrocytes
1
1980
346
0.020
Why?
Mice
1
2010
6206
0.020
Why?
Blood Platelets
1
1980
281
0.020
Why?
Animals
1
2010
16416
0.010
Why?
Child
1
1980
4342
0.010
Why?

Visualizations


Heckler's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department